U.S. Court in Massachusetts Orders Janssen to Produce Documents Shared with Consultants in Whistleblower Action Alleging Kickbacks
- June 27, 2025
A federal court in Massachusetts ordered Janssen Biotech, Inc. to produce certain documents it withheld or redacted in a qui tam action alleging the pharmaceutical company violated the Anti-Kickback Statute and caused the submission of false claims by providing free business advisory services to physicians who prescribed its infusible drugs, Remicade and Simponi ARIA.
ARTICLE TAGS
You must be logged in to access this content.